Article Text

PDF
Impaired portal circulation resulting from L-arginine deficiency in patients with lysinuric protein intolerance
  1. T Takeda1,
  2. H Watanabe1,
  3. T Saito1,
  4. K Saito1,
  5. H Takeda1,
  6. H Togashi1,
  7. J Fujii2,
  8. Y Takasago3,
  9. S Kawata4
  1. 1Department of Gastroenterology, Faculty of Medicine, Yamagata University, Yamagata, Japan
  2. 2Department of Biochemistry, Faculty of Medicine, Yamagata University, Yamagata, Japan
  3. 3Morioka Children’s Hospital, Morioka, Japan
  4. 4Department of Gastroenterology, Faculty of Medicine, Yamagata University, Yamagata, Japan
  1. Correspondence to:
    Professor S Kawata
    Department of Gastroenterology, Faculty of Medicine, Yamagata University, 2-2-2 Iida-nishi, Yamagata 990-9585, Japan; kawata{at}med.id.yamagata-u.ac.jp

Statistics from Altmetric.com

Lysinuric protein intolerance (LPI) is a rare autosomal recessive defect of the dibasic amino acid transporter, which is caused by mutations in the SLC7A7 gene and results in L-arginine deficiency.1 L-arginine is the only known substrate for nitric oxide (NO) production,2 and thus the availability of L-arginine is crucial for regulation of NO production.3 NO is an endothelium derived vascular relaxation factor that plays an important role in vascular endothelial function.4–6 However, the effects of L-arginine deficiency on portal circulation in humans have not been studied.

Portal circulation was evaluated in seven Japanese LPI patients (six males). Seven healthy subjects (six males) without liver disease served as controls. The study was approved by the ethics committee of our university. Mean age of the LPI patients was 18.9 (10.7) years (range 5–32) and that of the controls …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.